NCT06548152View on ClinicalTrials.gov

AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Lymphocytic Leukemia
Trial Locations (1)

Unknown

RECRUITING

Research Site, Saint-Affrique

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Hospitalidee

UNKNOWN

collaborator

Hospitalidee has been asserted to be a valid organization name by UHToulouse

UNKNOWN

lead

AstraZeneca

INDUSTRY